Insiders who reported open-market trades in the last 12 months at the companies Jeffrey M. Leiden files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Amit Sachdev - $28.38M in VRTX purchases and sales in the last 12 months
TPG GP A, LLC - $25.00M in ODTX purchases and sales in the last 12 months
Jeffrey M. Leiden is a corporate insider of Odyssey Therapeutics, Inc. (ODTX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jeffrey M. Leiden last file a Form 4?
The most recent primary Form 4 on record is dated 12 May 2026, one of 6 filings going back to 2025.
Has Jeffrey M. Leiden been buying or selling stock?
Recorded transactions: 1 open-market purchase ($100K) and 17 open-market sales ($60.94M) across all tracked filings.
Jeffrey M. Leiden files SEC Form 4 reports at Odyssey Therapeutics, Inc. (ODTX). 6 SEC Form 4 filings on record going back to 2025, most recently on 12 May 2026. Most recent open-market trade: bought $100K of ODTX on 12 May 2026. Lifetime open-market purchases: $100K. Lifetime open-market sales: $60.94M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Jeffrey M. Leiden.
InsiderAlpha's records for Jeffrey M. Leiden go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $100K (1 buy totaling $100K). The largest single buy on record is $100K of ODTX in 2026. Sales side: 17 recorded sales totaling $60.94M, so the filing history runs sell-heavy by dollar value. 27 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
